Teleflex | TFX - 销售成本



金融业
股票价格
USD
资产
USD 6.95B
现金及等价物
USD 354M
销售成本
USD 261.54M
流动资产
USD 1.94B
流动负债
USD 762.03M
债务
USD 2.77B
股息收益率
1.11
EBIT
USD 36.34M
EBITDA
USD -328.81M
员工
14.1K
EPS每股收益
USD 1.93
股本和储备
USD 3.12B
销售毛利
USD 307.45M
债务利息支出
USD 28.15M
利息收入
USD -9.24
贷款资金
USD 2.54B
市值
USD 6.38B
净收入
USD -714.33M
营业费用
USD 532.64M
营业利润
USD 36.34M
普通股股本
USD 44.19M
PE价格收益
27.79
税前利润
USD -438.58M
销售收入
USD 568.98M
销售和管理费用
USD 222.37M
股票
USD 802.47M
贸易债权人
USD 130.2M
应收帐款人
USD 345.58M


销售成本 更改 日
Abbott USD 5.3B 380M 2026-03
Align Technology USD 363.97M 7.48M 2025-12
AngioDynamics USD 37.29M 786K 2025-09
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.83B 8M 2026-03
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
General Electric Aerospace USD 8.15B 764M 2026-03
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Orthofix International USD 66.63M 6.4M 2025-12
ResMed USD 555.85M 29.13M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03